As of April 9, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,714 confirmed measles cases across 33 U.S. jurisdictions this year, up 43 from the prior week amid sustained outbreaks in states like Utah (over 500 cases), South Carolina, Texas, Arizona, and Florida. Declining vaccination rates in under-immunized communities, combined with international travel-linked importations, drive transmission of this highly contagious paramyxovirus, which spreads via respiratory droplets with an R0 of 12–18 in susceptible groups. Hospitalizations exceed 10% of cases per CDC data, with no fatalities reported yet. Traders should monitor weekly CDC surveillance summaries—next expected around April 16–23—and state-level reports through April 30, as reporting lags and intensified vaccination efforts could influence final tallies nearing market resolution.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourCas de rougeole aux États-Unis d'ici le 30 avril ?
Cas de rougeole aux États-Unis d'ici le 30 avril ?
$194,638 Vol.
$194,638 Vol.
30 avr. 2026
1800
61%
1850
21%
1900
7%
1950
3%
2000
3%
2100
2%
2200
2%
$194,638 Vol.
$194,638 Vol.
30 avr. 2026
1800
$52,036 Vol.
61%
1850
$5,501 Vol.
21%
1900
$50,792 Vol.
7%
1950
$20,403 Vol.
3%
2000
$42,683 Vol.
3%
2100
$7,283 Vol.
2%
2200
$15,939 Vol.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,714 confirmed measles cases across 33 U.S. jurisdictions this year, up 43 from the prior week amid sustained outbreaks in states like Utah (over 500 cases), South Carolina, Texas, Arizona, and Florida. Declining vaccination rates in under-immunized communities, combined with international travel-linked importations, drive transmission of this highly contagious paramyxovirus, which spreads via respiratory droplets with an R0 of 12–18 in susceptible groups. Hospitalizations exceed 10% of cases per CDC data, with no fatalities reported yet. Traders should monitor weekly CDC surveillance summaries—next expected around April 16–23—and state-level reports through April 30, as reporting lags and intensified vaccination efforts could influence final tallies nearing market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Marché ouvert : Mar 27, 2026, 1:49 PM ET
Volume
$194,638Date de fin
30 avr. 2026Marché ouvert
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,714 confirmed measles cases across 33 U.S. jurisdictions this year, up 43 from the prior week amid sustained outbreaks in states like Utah (over 500 cases), South Carolina, Texas, Arizona, and Florida. Declining vaccination rates in under-immunized communities, combined with international travel-linked importations, drive transmission of this highly contagious paramyxovirus, which spreads via respiratory droplets with an R0 of 12–18 in susceptible groups. Hospitalizations exceed 10% of cases per CDC data, with no fatalities reported yet. Traders should monitor weekly CDC surveillance summaries—next expected around April 16–23—and state-level reports through April 30, as reporting lags and intensified vaccination efforts could influence final tallies nearing market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$194,638Date de fin
30 avr. 2026Marché ouvert
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...As of April 9, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,714 confirmed measles cases across 33 U.S. jurisdictions this year, up 43 from the prior week amid sustained outbreaks in states like Utah (over 500 cases), South Carolina, Texas, Arizona, and Florida. Declining vaccination rates in under-immunized communities, combined with international travel-linked importations, drive transmission of this highly contagious paramyxovirus, which spreads via respiratory droplets with an R0 of 12–18 in susceptible groups. Hospitalizations exceed 10% of cases per CDC data, with no fatalities reported yet. Traders should monitor weekly CDC surveillance summaries—next expected around April 16–23—and state-level reports through April 30, as reporting lags and intensified vaccination efforts could influence final tallies nearing market resolution.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes